Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
Public ClinicalTrials.gov record NCT04819776. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iloperidone for 4 Weeks in the Treatment of Patients With Acute Manic Episodes Associated With Bipolar I Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The aim of this study is to investigate the efficacy, safety, and tolerability of iloperidone compared with placebo in treating acute manic or mixed episodes associated with Bipolar I Disorder.
Study identification
- NCT ID
- NCT04819776
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 417 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 22, 2021 (Actual)
- Primary completion
- Sep 7, 2022 (Actual)
- Completion
- Aug 16, 2023 (Actual)
- Last update posted
- Apr 18, 2024
2021 – 2023
United States locations
- U.S. sites
- 20
- U.S. states
- 10
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanda Investigational Site | Little Rock | Arkansas | 72211 | — |
| Vanda Investigational Site | Rogers | Arkansas | 72758 | — |
| Vanda Investigational Site | Cerritos | California | 90703 | — |
| Vanda Investigational Site | Culver City | California | 90230 | — |
| Vanda Investigational Site | Long Beach | California | 90806 | — |
| Vanda Investigational Site | Orange | California | 92868 | — |
| Vanda Investigational Site | Torrance | California | 90502 | — |
| Vanda Investigational Site | Miami Lakes | Florida | 33016 | — |
| Vanda Investigational Site | Oakland Park | Florida | 33334 | — |
| Vanda Investigational Site | Atlanta | Georgia | 30331 | — |
| Vanda Investigational Site | Decatur | Georgia | 30030 | — |
| Vanda Investigational Site | Gaithersburg | Maryland | 20877 | — |
| Vanda Investigational Site | Flowood | Mississippi | 39232 | — |
| Vanda Investigational Site | Las Vegas | Nevada | 89102 | — |
| Vanda Investigational Site | Marlton | New Jersey | 08053 | — |
| Vanda Investigational Site | Dayton | Ohio | 45417 | — |
| Vanda Investigational Site | North Canton | Ohio | 44720 | — |
| Vanda Investigational Site | Austin | Texas | 78754 | — |
| Vanda Investigational Site | DeSoto | Texas | 75115 | — |
| Vanda Investigational Site | Richardson | Texas | 75080 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04819776, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 18, 2024 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04819776 live on ClinicalTrials.gov.